VHL and cancer: Taken together, relying only on ‘proliferation’ data in vitro and in vivo with the currently available pre-clinical models is not adequate to determine the comprehensive tumor suppressive/promoting effects of HIF1α (or HIF-VHL pathway) in human cancer.